Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Emerging precision neoadjuvant systemic therapy for patients with resectable non-small cell lung cancer: current status and perspectives
Over the past decade, targeted therapy for oncogene-driven NSCLC and immune
checkpoint inhibitors for non-oncogene-driven NSCLC, respectively, have greatly improved …
checkpoint inhibitors for non-oncogene-driven NSCLC, respectively, have greatly improved …
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Lung cancer is the leading cause of cancer mortality worldwide with 1.8 million newly
diagnosed cases, or 13% of all cancers diagnosed, in 2012 [1]. The worldwide numbers are …
diagnosed cases, or 13% of all cancers diagnosed, in 2012 [1]. The worldwide numbers are …
Risk stratification in lung resection
Abstract Purpose of Review Surgery is considered the best treatment option for patients with
early stage lung cancer. Nevertheless, lung resection may cause a variable functional …
early stage lung cancer. Nevertheless, lung resection may cause a variable functional …
Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer: American College of …
Background This section of the guidelines is intended to provide an evidence-based
approach to the preoperative physiologic assessment of a patient being considered for …
approach to the preoperative physiologic assessment of a patient being considered for …
[HTML][HTML] 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
J Vansteenkiste, L Crino, C Dooms, JY Douillard… - Annals of …, 2014 - Elsevier
To complement the existing treatment guidelines for all tumour types, ESMO organises
consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO …
consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO …
[HTML][HTML] Definition and assessment of high risk in patients considered for lobectomy for stage I non–small cell lung cancer: The American Association for Thoracic …
Objective Lobectomy is a standard treatment for stage I non–small cell lung cancer, but a
significant proportion of patients are considered at high risk for complications, including …
significant proportion of patients are considered at high risk for complications, including …
[HTML][HTML] Anesthetic considerations for lung resection: preoperative assessment, intraoperative challenges and postoperative analgesia
D Lederman, J Easwar, J Feldman… - Annals of translational …, 2019 - ncbi.nlm.nih.gov
This article is intended to provide a general overview of the anesthetic management for lung
resection surgery including the preoperative evaluation of the patient, factors influencing the …
resection surgery including the preoperative evaluation of the patient, factors influencing the …
[HTML][HTML] Diagnosis and management of peripheral lung nodule
A solitary pulmonary nodule (SPN) is a well-defined radiographic opacity up to 3 cm in
diameter that is surrounded by unaltered aerated lung. Frequently, it is an incidental finding …
diameter that is surrounded by unaltered aerated lung. Frequently, it is an incidental finding …
The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all …
LM Vernooij, WA van Klei, KGM Moons… - Cochrane Database …, 2021 - cochranelibrary.com
Background The Revised Cardiac Risk Index (RCRI) is a widely acknowledged prognostic
model to estimate preoperatively the probability of develo** in‐hospital major adverse …
model to estimate preoperatively the probability of develo** in‐hospital major adverse …
Prognostic value of 6-min walk test to predict postoperative cardiopulmonary complications in patients with non-small cell lung cancer
Background The risk stratification value of the 6-min walk test (6MWT) to decide the
feasibility of surgical resection is not well elucidated in patients with non-small cell lung …
feasibility of surgical resection is not well elucidated in patients with non-small cell lung …